1. Home
  2. XELB vs GTBP Comparison

XELB vs GTBP Comparison

Compare XELB & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xcel Brands Inc.

XELB

Xcel Brands Inc.

N/A

Current Price

$2.12

Market Cap

10.6M

Sector

Miscellaneous

ML Signal

N/A

Logo GT Biopharma Inc.

GTBP

GT Biopharma Inc.

HOLD

Current Price

$0.34

Market Cap

8.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XELB
GTBP
Founded
2011
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
8.8M
IPO Year
2011
2016

Fundamental Metrics

Financial Performance
Metric
XELB
GTBP
Price
$2.12
$0.34
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
22.6K
687.4K
Earning Date
04-07-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
48.37
3.75
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$102.11
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.74
$0.26
52 Week High
$3.17
$3.73

Technical Indicators

Market Signals
Indicator
XELB
GTBP
Relative Strength Index (RSI) 52.26 44.10
Support Level $2.00 $0.26
Resistance Level $2.23 $0.48
Average True Range (ATR) 0.17 0.04
MACD -0.02 0.01
Stochastic Oscillator 25.51 53.00

Price Performance

Historical Comparison
XELB
GTBP

About XELB Xcel Brands Inc.

Xcel Brands Inc is a media and brand management company. It is engaged in design, merchandising and planning, sourcing and production, licensing, marketing, and brand development. The company offers branded apparel, footwear, accessories, jewelry, home goods, and other consumer products. Its brand portfolio consists of the Isaac Mizrahi, Judith Ripka, H Halston, C Wonder, and the Highline Collective brands. The company licenses its brands to third parties, provides certain designs, production, and marketing services, and generates licensing, design, and service fee revenues through contractual arrangements and other agreements.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: